Abiomed (ABMD) Guides FY12 Sales Above the Street
Tweet
Share
E-mailGet Alerts ABMD Hot Sheet
Join SI Premium – FREE
Abiomed (Nasdaq: ABMD) sees FY12 sales up 20-24 percent, which would imply sales of $152-$157 million, which compares to the Street estimate of $124.16 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- General Mills (GIS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
